Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Guillermo Martínez Díaz‐Guerra"'
Autor:
Santos Castañeda, Carmen Navarro Ceballos, Jaqueline Usón Jaeger, Carolina de Miguel Benadiba, Esteban Gómez Martín, Guillermo Martínez Díaz-Guerra, Luis Alvarez-Galovich
Publikováno v:
Geriatrics, Vol 9, Iss 2, p 24 (2024)
Vertebral fragility fractures (VFF) pose a challenge for appropriate care. The aim of this study was to develop consensus recommendations for the management of VFF in older people from a multidisciplinary approach. Specialists in osteoporosis belongi
Externí odkaz:
https://doaj.org/article/810cc9b524674377b16aa9ebafff0140
Autor:
Federico Hawkins Carranza, Sonsoles Guadalix Iglesias, María Luisa De Mingo Domínguez, Cristina Martín‐Arriscado Arroba, Begoña López Álvarez, Gonzalo Allo Miguel, Guillermo Martínez Díaz‐Guerra
Publikováno v:
Cancer Medicine, Vol 9, Iss 16, Pp 5746-5755 (2020)
Abstract Background Conflicting results has been reported regard osteoporosis and fractures in patients with Differentiated Thyroid Cancer (DTC). Our objective was to evaluate the long‐term effects of TSH suppression therapy with Levothyroxine (LT4
Externí odkaz:
https://doaj.org/article/d173a3dfcbea41c2854cee264114dee8
Autor:
Soledad Librizzi, Gonzalo Allo Miguel, Gema Villa, Mercedes Aramendi, Federico Hawkins, Miguel León Sanz, Guillermo Martínez Díaz-Guerra
Publikováno v:
Bone Reports, Vol 14, Iss , Pp 100986- (2021)
Externí odkaz:
https://doaj.org/article/c09c6d74a5a0421d92b2c1e40cdc9f1a
Autor:
Yentl Huybrechts, Eveline Boudin, Gretl Hendrickx, Ellen Steenackers, Neveen Hamdy, Geert Mortier, Guillermo Martínez Díaz-Guerra, Milagros Sierra Bracamonte, Natasha M. Appelman-Dijkstra, Wim Van Hul
Publikováno v:
Genes, Vol 13, Iss 1, p 80 (2021)
Sclerosteosis is a high bone mass disorder, caused by pathogenic variants in the genes encoding sclerostin or LRP4. Both proteins form a complex that strongly inhibits canonical WNT signaling activity, a pathway of major importance in bone formation.
Externí odkaz:
https://doaj.org/article/8a52c304f26c4eeab6a7055f01d149f1
Autor:
María Soledad Librizzi, MD, Lucas Arroyave, MD, Elena García, MD, Alicia Serraclara, MD, María Maíz, MD, Guillermo Martínez Díaz-Guerra, MD, PhD, Federico Hawkins, MD, PhD
Publikováno v:
AACE Clinical Case Reports, Vol 3, Iss 2, Pp e111-e115 (2017)
ABSTRACT: Objective: Erdheim-Chester disease (ECD) is a rare, non-Langerhans histiocytosis of unknown origin with characteristic radiologic and histologic features.Methods: This report describes a patient with multiple endocrine manifestations in the
Externí odkaz:
https://doaj.org/article/933e8cfbab0c4d119d720322a8ea5c91
Autor:
Gonzalo Allo Miguel, Alicia Serraclara Plá, Myriam Lorena Partida Muñoz, Guillermo Martínez Díaz-Guerra, Federico Hawkins
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 7 (2016)
Background: Adult growth hormone deficiency (AGHD) is characterized by impaired physical activity, diminished quality of life (QoL), weight and fat mass gain, decreased muscle mass and decreased bone mineral density (BMD). The aim of this study was t
Externí odkaz:
https://doaj.org/article/e330250e69c84aa59e32c702d9c05a3c
Publikováno v:
Journal of Pediatric Endocrinology and Metabolism. 36:505-507
Objectives Hypoparathyroidism (HypoPT) is a rare disorder and non-surgical cases require careful evaluation, since may be due to genetic, autoimmune, or metabolic factors. Case presentation We present a 15-year-old girl with a previous diagnosis of m
Autor:
Santos Castañeda, Ana Casas, Aránzazu González-del-Alba, Guillermo Martínez-Díaz-Guerra, Xavier Nogués, Cristina Ojeda Thies, Óscar Torregrosa Suau, Álvaro Rodríguez-Lescure
Publikováno v:
Clinical and Translational Oncology. 24:2090-2106
Cancer and cancer therapies are a major factor risk for osteoporosis due to bone loss and deterioration of bone microarchitecture. Both factors contribute to a decrease in bone strength and, consequently, increased bone fragility and risk of fracture
Autor:
Domingo González-Lamuño, Ana Lorente Rodríguez, María Isabel Luis Yanes, Silvia Marín-del Barrio, Guillermo Martínez Díaz-Guerra, Pilar Peris
Publikováno v:
Medicina Clínica Volume 159, Issue 3, 12 August 2022, Pages 152.e1-152.e12
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Antecedentes y objetivo: El objetivo de este proyecto fue adaptar la primera guía de práctica clínica en la hipofosfatemia ligada al cromosoma X (XLH) aparecida en 2019 a nuestro medio siguiendo un proceso sistemático basado en el método ADAPTE.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9144c97f6775b34816526ff1fb984645
http://hdl.handle.net/10902/24585
http://hdl.handle.net/10902/24585
Autor:
Begoña López Alvarez, Federico Hawkins Carranza, Gonzalo Allo Miguel, María Luisa De Mingo Dominguez, Cristina Martín-Arriscado Arroba, Sonsoles Guadalix Iglesias, Guillermo Martínez Díaz-Guerra
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 9, Iss 16, Pp 5746-5755 (2020)
Cancer Medicine, Vol 9, Iss 16, Pp 5746-5755 (2020)
Background Conflicting results has been reported regard osteoporosis and fractures in patients with Differentiated Thyroid Cancer (DTC). Our objective was to evaluate the long‐term effects of TSH suppression therapy with Levothyroxine (LT4) on trab